DIAMOND BIOFUND INC - Asset Resilience Ratio

Latest as of December 2025: 12.12%

DIAMOND BIOFUND INC (6901) has an Asset Resilience Ratio of 12.12% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$1.13 Billion
≈ $35.75 Million USD Cash + Short-term Investments

Total Assets

NT$9.36 Billion
≈ $294.85 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how DIAMOND BIOFUND INC's Asset Resilience Ratio has changed over time. See DIAMOND BIOFUND INC (6901) flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down DIAMOND BIOFUND INC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is DIAMOND BIOFUND INC worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$1.13 Billion 12.12%
Total Liquid Assets NT$1.13 Billion 12.12%

Asset Resilience Insights

  • Moderate Liquidity: DIAMOND BIOFUND INC has 12.12% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

DIAMOND BIOFUND INC Industry Peers by Asset Resilience Ratio

Compare DIAMOND BIOFUND INC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Apollo Global Management LLC Class A
NYSE:APO
Asset Management 49.33%
Julius Baer Gruppe AG
SW:BAER
Asset Management 15.49%
Sofina Société Anonyme
BR:SOF
Asset Management 4.11%
KBC Ancora
BR:KBCA
Asset Management 1.63%
Stepstone Group Inc
NASDAQ:STEP
Asset Management -1.13%
Norte Grande
SN:NORTEGRAN
Asset Management 0.00%
A.F.P. Provida
SN:PROVIDA
Asset Management 5.53%
Ninety One PLC
JSE:N91
Asset Management 91.80%

Annual Asset Resilience Ratio for DIAMOND BIOFUND INC (2019–2025)

The table below shows the annual Asset Resilience Ratio data for DIAMOND BIOFUND INC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 12.12% NT$1.13 Billion
≈ $35.75 Million
NT$9.36 Billion
≈ $294.85 Million
-34.75pp
2024-12-31 46.88% NT$5.00 Billion
≈ $157.65 Million
NT$10.67 Billion
≈ $336.31 Million
-10.97pp
2023-12-31 57.85% NT$7.54 Billion
≈ $237.68 Million
NT$13.04 Billion
≈ $410.89 Million
-35.09pp
2022-12-31 92.94% NT$10.40 Billion
≈ $327.79 Million
NT$11.19 Billion
≈ $352.69 Million
-1.85pp
2021-12-31 94.79% NT$10.07 Billion
≈ $317.24 Million
NT$10.62 Billion
≈ $334.68 Million
+9.31pp
2020-12-31 85.48% NT$7.93 Billion
≈ $249.93 Million
NT$9.28 Billion
≈ $292.38 Million
+58.10pp
2019-12-31 27.38% NT$843.00 Million
≈ $26.56 Million
NT$3.08 Billion
≈ $97.02 Million
--
pp = percentage points

About DIAMOND BIOFUND INC

TW:6901 Taiwan Asset Management
Market Cap
$437.98 Million
NT$13.90 Billion TWD
Market Cap Rank
#12725 Global
#463 in Taiwan
Share Price
NT$16.30
Change (1 day)
+3.49%
52-Week Range
NT$12.25 - NT$21.10
All Time High
NT$68.20
About

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.